What Is (+)-epi-alpha-bisabolol synthase

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 10, 2026

Quick Answer: (+)-epi-alpha-bisabolol synthase (EC 4.2.3.138) is a sesquiterpene synthase enzyme that catalyzes the first step in the biosynthesis of hernandulcin, a natural sweetener found in Phyla dulcis (Aztec sweet herb). The enzyme converts farnesyl diphosphate into (+)-epi-alpha-bisabolol with kinetic properties of Km 4.8 μM and kcat 0.04 s⁻¹. It represents a key target for biotechnological production of sesquiterpene derivatives in engineered organisms like Saccharomyces cerevisiae.

Key Facts

Enzyme classification EC 4.2.3.138; belongs to the sesquiterpene synthase family of lyases that produce C15 natural products from farnesyl diphosphate
Catalyzes the first committed step in hernandulcin biosynthesis pathway in Phyla dulcis, a plant traditionally used as a natural sweetener
Recombinant enzyme exhibits Km value of 4.8 μM and turnover number (kcat) of 0.04 s⁻¹ under standard assay conditions
Engineered Saccharomyces cerevisiae strains expressing the enzyme achieved biosynthesis of approximately 0.3 mg/mL of α-bisabolol in shake-flask cultivation
Related to chamomile (-)-α-bisabolol synthase which produces 8 mg/L of sesquiterpene in microbial fermentation systems

Overview

(+)-epi-alpha-bisabolol synthase is a specialized enzyme belonging to the terpene synthase family, classified as EC 4.2.3.138 in the enzymatic classification system. This sesquiterpene synthase catalyzes a critical cyclization reaction that transforms farnesyl diphosphate (a C15 isoprenoid precursor) into (+)-epi-alpha-bisabolol, a sesquiterpene alcohol with significant biological importance. The enzyme was first isolated and characterized from Phyla dulcis, commonly known as Aztec sweet herb, where it functions as a key metabolic step in the production of hernandulcin.

The discovery and characterization of this enzyme emerged from research into natural sweetening compounds produced by medicinal plants. Scientists identified the enzyme through molecular cloning techniques and demonstrated its ability to catalyze stereospecific cyclization reactions with high selectivity. The enzyme's role in the hernandulcin biosynthetic pathway highlights how plants synthesize complex secondary metabolites through enzymatic cascades. Understanding the structure and function of (+)-epi-alpha-bisabolol synthase has enabled researchers to exploit this enzyme for biotechnological applications, particularly in microbial fermentation systems engineered to produce valuable sesquiterpene compounds.

How It Works

(+)-epi-alpha-bisabolol synthase operates as a lyase enzyme, catalyzing reactions that form new carbon-carbon bonds while cleaving high-energy diphosphate bonds. The enzyme mechanism involves recognition of farnesyl diphosphate as substrate and initiation of a complex cyclization cascade that generates the characteristic bicyclic structure of bisabolol compounds.

Substrate Recognition: The enzyme specifically binds farnesyl diphosphate (FPP), a 15-carbon molecule generated through the isoprenoid biosynthetic pathway. This substrate recognition ensures pathway specificity and prevents promiscuous reactions with related substrates.
Ionization and Carbocation Formation: Upon substrate binding, the enzyme catalyzes diphosphate removal and generates a carbocation intermediate through a diphosphate-initiated ionization mechanism. This high-energy intermediate is stabilized by the enzyme's binding pocket and amino acid residues.
Cyclization Reaction: The resulting carbocation undergoes intramolecular cyclization through stereoselective C-C bond formation, generating the distinctive bicyclic structure characteristic of bisabolol compounds. The enzyme's three-dimensional structure directs the reaction pathway toward (+)-epi-alpha-bisabolol formation rather than alternative sesquiterpene isomers.
Product Release and Enzyme Recycling: Following product formation, the enzyme releases (+)-epi-alpha-bisabolol and regenerates its catalytically competent form, enabling multiple rounds of substrate turnover. The recombinant enzyme exhibits measurable kinetic parameters with Km 4.8 μM for substrate affinity and kcat 0.04 s⁻¹ for catalytic efficiency.

Key Comparisons

Characteristic	(+)-epi-α-Bisabolol Synthase	(-)-α-Bisabolol Synthase (Chamomile)	Other Sesquiterpene Synthases
Source Organism	Phyla dulcis (Aztec sweet herb)	Matricaria recutita (Chamomile)	Various medicinal plants and fungi
Primary Product	(+)-epi-alpha-bisabolol (precursor to hernandulcin)	(-)-alpha-bisabolol (used in cosmetics/fragrance)	Variable sesquiterpenes (germacrene, β-bisabolene, etc.)
Biotechnology Production	Engineered yeast: ~0.3 mg/mL in shake-flask	Engineered yeast: 8 mg/L de novo synthesis	Ranges from 1-50 mg/L depending on organism and optimization
Enzyme Classification	EC 4.2.3.138 (lyase)	EC 4.2.3.101 (lyase)	EC 4.2.3.x family (multiple specific enzymes)
Downstream Applications	Sweetener precursor (hernandulcin)	Cosmetic, fragrance, and pharmaceutical ingredient	Bioactive compounds with diverse applications

Why It Matters

Natural Product Synthesis: (+)-epi-alpha-bisabolol synthase represents a critical pathway for producing hernandulcin and related sesquiterpenes through enzymatic catalysis rather than chemical synthesis. This enzymatic approach offers sustainable and environmentally friendly production methods compared to organic chemistry routes.
Biotechnological Applications: The enzyme has been successfully integrated into synthetic biology platforms using engineered microorganisms, enabling fermentation-based production of valuable natural products. Yeast strains expressing the enzyme can synthesize target compounds de novo from simple carbon sources, reducing dependency on plant extraction.
Metabolic Engineering: Scientists have combined (+)-epi-alpha-bisabolol synthase with cytochrome P450 oxidases in yeast to create synthetic metabolic pathways that generate novel sesquiterpene derivatives. This strategy demonstrates how enzyme characterization enables creation of new bioactive compounds for pharmaceutical and industrial applications.
Plant Biology Understanding: Characterization of this enzyme contributes to fundamental understanding of how medicinal plants synthesize bioactive secondary metabolites. The structural and kinetic data inform broader knowledge of sesquiterpene biosynthesis in plant biochemistry.

The continued development of (+)-epi-alpha-bisabolol synthase research promises significant advances in sustainable production of natural compounds. As biotechnology techniques improve and enzyme engineering progresses, this enzyme may become increasingly important for pharmaceutical manufacturing, nutraceutical production, and creation of specialty chemicals. The work exemplifies how biochemical characterization of plant enzymes translates into practical biotechnological innovations that benefit multiple industries.